Highlander Capital Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $116K | Hold |
200
| – | – | 0.04% | 268 |
|
|
2023
Q4 | $106K | Hold |
200
| – | – | 0.04% | 284 |
|
|
2023
Q3 | $101K | Hold |
200
| – | – | 0.04% | 273 |
|
|
2023
Q2 | $104K | Hold |
200
| – | – | 0.05% | 227 |
|
|
2023
Q1 | $115K | Hold |
200
| – | – | 0.06% | 209 |
|
|
2022
Q4 | $110K | Hold |
200
| – | – | 0.06% | 208 |
|
|
2022
Q3 | $101K | Sell |
200
-100
| -33% | -$56K | 0.06% | 203 |
|
|
2022
Q2 | $163K | Hold |
300
| – | – | 0.09% | 158 |
|
|
2022
Q1 | $177K | Hold |
300
| – | – | 0.08% | 161 |
|
|
2021
Q4 | $200K | Hold |
300
| – | – | 0.09% | 148 |
|
|
2021
Q3 | $171K | Hold |
300
| – | – | 0.09% | 158 |
|
|
2021
Q2 | $151K | Buy |
300
+100
| +50% | +$47.2K | 0.08% | 176 |
|
|
2021
Q1 | $91K | Sell |
200
-30
| -13% | -$14.3K | 0.05% | 224 |
|
|
2020
Q4 | $107K | Hold |
230
| – | – | 0.06% | 203 |
|
|
2020
Q3 | $102K | Hold |
230
| – | – | 0.06% | 199 |
|
|
2020
Q2 | $83K | Hold |
230
| – | – | 0.05% | 215 |
|
|
2020
Q1 | $65K | Hold |
230
| – | – | 0.05% | 244 |
|
|
2019
Q4 | $75K | Hold |
230
| – | – | 0.04% | 245 |
|
|
2019
Q3 | $67K | Hold |
230
| – | – | 0.04% | 266 |
|
|
2019
Q2 | $68K | Hold |
230
| – | – | 0.04% | 280 |
|
|
2019
Q1 | $63K | Hold |
230
| – | – | 0.04% | 290 |
|
|
2018
Q4 | $50K | Hold |
230
| – | – | 0.03% | 310 |
|
|
2018
Q3 | $56K | Hold |
230
| – | – | 0.03% | 337 |
|
|
2018
Q2 | $48K | Hold |
230
| – | – | 0.03% | 362 |
|
|
2018
Q1 | $47K | Hold |
230
| – | – | 0.03% | 364 |
|
|
2017
Q4 | $44K | Hold |
230
| – | – | 0.03% | 372 |
|
|
2017
Q3 | $44K | Hold |
230
| – | – | 0.03% | 374 |
|
|
2017
Q2 | $40K | Hold |
230
| – | – | 0.03% | 386 |
|
|
2017
Q1 | $35K | Hold |
230
| – | – | 0.03% | 406 |
|
|
2016
Q4 | $32K | Hold |
230
| – | – | 0.03% | 425 |
|
|
2016
Q3 | $37K | Hold |
230
| – | – | 0.03% | 409 |
|
|
2016
Q2 | $34K | Hold |
230
| – | – | 0.03% | 428 |
|
|
2016
Q1 | $33K | Hold |
230
| – | – | 0.03% | 431 |
|
|
2015
Q4 | $33K | Hold |
230
| – | – | 0.03% | 435 |
|
|
2015
Q3 | $28K | Buy |
230
+1
| +0.4% | +$130 | 0.03% | 477 |
|
|
2015
Q2 | $30K | Hold |
229
| – | – | 0.03% | 462 |
|
|
2015
Q1 | $31K | Hold |
229
| – | – | 0.03% | 473 |
|
|
2014
Q4 | $29K | Hold |
229
| – | – | 0.03% | 484 |
|
|
2014
Q3 | $27.9K | Buy |
229
+1
| +0.4% | +$122 | 0.03% | 464 |
|
|
2014
Q2 | $27K | Hold |
228
| – | – | 0.02% | 471 |
|
|
2014
Q1 | $27.5K | Hold |
228
| – | – | 0.03% | 458 |
|
|
2013
Q4 | $25.4K | Buy |
228
+1
| +0.4% | +$99 | 0.02% | 463 |
|
|
2013
Q3 | $21K | Hold |
227
| – | – | 0.02% | 506 |
|
|
2013
Q2 | $19.3K | Buy |
+227
| New | +$18.9K | 0.02% | 516 |
|
Other funds holding TMO
Highlander Capital Management's TMO Position: Q1 2024 in Review
Highlander Capital Management held its Thermo Fisher Scientific (TMO) position steady in Q1 2024 at 200 shares worth $116K. The position accounts for 0.04% of the portfolio, ranked #268.
Highlander Capital Management first reported a position in TMO in Q2 2013 and has held it in 44 quarters since. The position peaked at $200K in Q4 2021. 2,528 funds tracked by Wall St. Rank hold TMO as of Q1 2024.
- Highlander Capital Management held 200 shares of Thermo Fisher Scientific worth $116K as of Q1 2024.
- Highlander Capital Management left its Thermo Fisher Scientific share count unchanged in Q1 2024.
- Thermo Fisher Scientific made up 0.04% of Highlander Capital Management's portfolio in Q1 2024, its #268 holding.
- Highlander Capital Management first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 44 quarters since.
- Highlander Capital Management's Thermo Fisher Scientific position peaked at $200K in Q4 2021.
- 2,528 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2024.
Based on Highlander Capital Management's 13F filing for Q1 2024, filed 20 May 2024.